FISPB
ADPT icon

Fideuram - Intesa Sanpaolo Private Banking’s Adaptive Biotechnologies ADPT Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Buy
+202,097
New +$3.1M 0.13% 164

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's ADPT Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 202,097 shares worth $4.33M. The stake represents 0.13% of the portfolio and ranks #164 among its holdings.

123 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 202,097 shares of Adaptive Biotechnologies worth $4.33M as of Q2 2026.
  • Adaptive Biotechnologies was a new Fideuram - Intesa Sanpaolo Private Banking position in Q2 2026.
  • Adaptive Biotechnologies made up 0.13% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #164 holding.
  • 123 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.